CIK 0001827635
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Veradermics, Inc
Sign in to watch- Ticker
- MANE
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 843304423
- Phone
- +1 228-372-3376
- Business address
- 470 JAMES STREET, NEW HAVEN, CT, 06513
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $230,817,500
- in 3 filings
Net −$230,817,500. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-17 | Durso Timothy August Chief Technical Officer | Option exercise 10b5-1 | +3,452 | $12.19 | $42K | 121,642 |
| 2026-08-17 | Durso Timothy August Chief Technical Officer | Sale 10b5-1 | −7,918 | $106.71 | $845K | 113,724 |
| 2026-08-17 | Durso Timothy August Chief Technical Officer | Sale 10b5-1 | −16,306 | $107.52 | $1.8M | 97,418 |
| 2026-08-17 | Durso Timothy August Chief Technical Officer | Sale 10b5-1 | −16,767 | $108.38 | $1.8M | 80,651 |
| 2026-08-17 | Durso Timothy August Chief Technical Officer | Sale 10b5-1 | −2,348 | $109.34 | $257K | 78,303 |
| 2026-08-17 | Durso Timothy August Chief Technical Officer | Sale 10b5-1 | −161 | $111.28 | $18K | 78,142 |
| 2026-08-17 | Durso Timothy August Chief Technical Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −3,452 | 0 | ||
| 2026-02-05 | Durso Timothy August Chief Technical Officer | Conversion | +1,473 | 118,190 | ||
| 2026-02-05 | Durso Timothy August Chief Technical Officer | Conversion · Series A Convertible Preferred Stock | −1,473 | 0 | ||
| 2026-02-03 | Durso Timothy August Chief Technical Officer | Grant or award · Stock Option (Right to Buy) | +213,352 | 213,352 |
Page 1 of 1 · 10 trades